Monday, July 25, 2011

David Buswell

The following statements were released July 23, 2011 by David Buswell COO of Immune Response BioPharma.

"We are proud of the work we have done in such a short period of time. There remains much outstanding work to do. IRBP has a great pipeline and we have multiple goals on shot with our NeuroVax MS Vaccine the technology, with applications of the drug in RA with our drug RAVAX. We believe REMUNE holds the safest and most effective treatment option for HIV/AIDS the HAART drugs are just plain toxic and poisonous, I am committed to saving lives and getting patients the vaccine” Mr. Buswell COO.

“REMUNE is a winner hands down and see the vaccine as the gold standard of treatment, eventually 90% market share , as soon as we have clarity on CGMP’s manufacturing we will press forward on an NDA for REMUNE. I believe we are close to receiving funding and support from a prominent businessman and we will move forward building a dynamic pharmaceutical company to save lives. Those who wait to partner with IRBP and wait to collaborate including big pharma will lose out” Mr. Buswell COO."

It is interesting that he was able to take research from Immune Reponse Corporation aka Orchestra
Therapeutics and now offers the "gold standard" as they put it. Immune/Orchestra continually returned failed test results using the same research and science to the point that Pfizer gave up and abandoned them. The investors lost all their money, the employees all left, the compnay was unable to obtain any financing or grants and finally it was forced into bankruptcy. Now along comes Mr. Buswell and he declares the research a "gold mine." If it was "gold" why did it not attract investors before? Why were the test results from clinical trials always failures? Why did reputable researchers and scientists accuse the company of trying to manipultate and hide poor test result findings? Why could the company not obtain any grant funding? Why did Wall Street and its investors abandon the company?

Why did Kevin Kimberlin and Spencer Trask continue to give the company money in exchange for the intellectual property rights to the research right up to the moment the company filed bankruptcy? How did David Buswell and Immune Response BioPharma obtain the research files, papers, digital data, clinical results, and patient records?

We would all like to see patients cured, but we would also like to see the business behind it done in a proper, legal, and morally acceptable manner. It should not be done through manipulation in order that the original investors are cheated and abandoned and all the profits go to the insiders who were pulling the strings on the demise of Immune Response Corporation and Orchestra Therapeutics.

Tuesday, July 12, 2011

Kevin Kimberlin, Spencer Trask, and David Buswell, Immune Response

I have writen to Immune Response Biopharma and Spencer Trask several times asking if Spencer Trask or Kevin Kimberlin were involved in the financial support or creation of the Immune Response Biopharma company which is now laying claims to the research financed by the investors of Immune Response Corportation and Orchestra Therapeutics, Inc. The only response I have received back is threatening letters from David Buswell. They refuse to say if Kevin Kimberlin and Spencer Trask is involved in Immune Response BioPharma or not. I wonder what to make of that.

Wednesday, July 6, 2011

Spencer Trask

I sent E-mails to both Immune Response BioPharma and Spencer Trask asking if Spencer Trask or Kevin Kimberlin were involved in the financing or managerment of Immune Response BioPharma. Hopefully I will receive a simple honest response.

Dear Sir or Madam:

It is my understanding that your company is claiming to now own the rights to the research conducted over the past twenty plus years by the Immune Response and Orchestra Therapeutic Corporations. Kevin Kimberlin and Spencer Trask were owners in these companies and purchased much of the intellectual property rights. Obviously, for those rights to have been abandoned legally there could be no involvement in Immune Response BioPharma by either Mr. Kimberlin or Spencer Trask as that would simply mean that they helped finance and start a new company under a new name and simply transferred the research rights in order to abandon the previous companies investors and make more profit for themselves.

I have a simple question. Is either Kevin Kimberlin or Spencer Trask involved in the financing or operation of Immune Response BioPharma?

Sincerely,
Joel Reese